(Q54456791)

30 May 2018

title

Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. (English)

1 reference

30 May 2018

0 references

0 references

Hatice Bilgic

1

1 reference

30 May 2018

Steven R Ytterberg

2

1 reference

30 May 2018

Shreyasee Amin

3

1 reference

30 May 2018

Kelly T McNallan

4

1 reference

30 May 2018

Joseph C Wilson

5

1 reference

30 May 2018

Thearith Koeuth

6

1 reference

30 May 2018

Sonja Ellingson

7

1 reference

30 May 2018

Brant Newman

8

1 reference

30 May 2018

Jason W Bauer

9

1 reference

30 May 2018

Erik J Peterson

10

1 reference

30 May 2018

Emily C Baechler

11

1 reference

30 May 2018

Ann M Reed

12

1 reference

30 May 2018

publication date

1 November 2009

1 reference

30 May 2018

published in

Arthritis and Rheumatism

1 reference

30 May 2018

volume

60

1 reference

30 May 2018

issue

11

1 reference

30 May 2018

page(s)

3436-3446

1 reference

30 May 2018

Genetic and environmental risk factors for idiopathic inflammatory myopathies

cites work

1 reference

Association of the HLA-DQA1*0501 allele in multiple racial groups with juvenile dermatomyositis

21 January 2018

1 reference

Update on the genetics of the idiopathic inflammatory myopathies.

21 January 2018

1 reference

Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis

21 January 2018

1 reference

Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.

21 January 2018

1 reference

Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis

21 January 2018

1 reference

MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement

21 January 2018

1 reference

A gene expression approach to study perturbed pathways in myositis

21 January 2018

1 reference

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

21 January 2018

1 reference

Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.

21 January 2018

1 reference

21 January 2018

1 reference

Anti-interleukin 6 receptor antibody treatment in rheumatic disease

21 January 2018

1 reference

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

21 January 2018

1 reference

Interleukin-6: from basic science to medicine--40 years in immunology

21 January 2018

1 reference

Interleukin-6 and chronic inflammation

21 January 2018

1 reference

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

21 January 2018

1 reference

Elevated serum levels of soluble CD154 in children with juvenile idiopathic arthritis

21 January 2018

1 reference

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

21 January 2018

1 reference

International consensus on preliminary definitions of improvement in adult and juvenile myositis.

21 January 2018

1 reference

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

21 January 2018

1 reference

The emerging role of interferon in human systemic lupus erythematosus

21 January 2018

1 reference

The type I interferon system in systemic lupus erythematosus

21 January 2018

1 reference

Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells

21 January 2018

1 reference

Interferons and scleroderma-a new clue to understanding the pathogenesis of scleroderma?

21 January 2018

1 reference

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.

21 January 2018

1 reference

The nature of the principal type 1 interferon-producing cells in human blood

21 January 2018

1 reference

Pathogenesis of myositis in children

21 January 2018

1 reference

Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis

21 January 2018

1 reference

Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies

21 January 2018

1 reference

Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy.

21 January 2018

1 reference

Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.

21 January 2018

1 reference

Increased IL-18 production by dendritic cells in active inflammatory myopathies

21 January 2018

1 reference

Naturally occurring NF-kappaB inhibitors

21 January 2018

1 reference

International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.24936

1 reference

30 May 2018

PubMed ID

19877033

1 reference

30 May 2018